ARCA biopharma, Inc. NOTICE OF GRANT OF STOCK OPTION

Exhibit 10.37

ARCA biopharma, Inc.

NOTICE OF GRANT OF STOCK OPTION

[                                         ] (the “Optionee”) has been granted an option (the “Option”) to purchase certain shares of Stock of ARCA biopharma, Inc. (f/k/a Nuvelo, Inc.) pursuant to the Nuvelo, Inc. 2004 Equity Incentive Plan, as amended to date (as amended, the “Plan”), as follows:

The total Exercise Price of the Option Shares granted is [$            ].

The Optionee’s right to purchase the Option Shares vests as follows: (i) 25% of the Option Shares vests one year after the Vesting Start Date, provided the Optionee remains in Service at the end of such one-year period, and (ii) 6.25% of the Option Shares vests at the end of each three-month period thereafter, provided the Optionee remains in Service at the end of each such period. The resulting aggregate number of vested Option Shares will be rounded to the nearest whole number, and the Optionee cannot vest in more than the number of Option Shares.

By their signatures below, the Company and the Optionee agree that the Option is governed by this Notice of Grant of Stock Option and by the provisions of the Plan and the attached Stock Option Agreement, both of which are attached to and made a part of this document. The Optionee acknowledges receipt of copies of the Plan and the Stock Option Agreement, represents that the Optionee has read and is familiar with their provisions, and hereby accepts the Option subject to all of their terms and conditions.